Literature DB >> 9686675

Plasma levels of nitric oxide products and endothelin in pulmonary hypertension with congenital heart disease.

Y Ikemoto, M Teraguchi, J Takaya, S Nogi, Y Kobayashi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9686675     DOI： 10.1080/080352598750014238

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN： 0803-5253            Impact factor:   2.299


× No keyword cloud information.
  3 in total

1.  Elevated homocysteine and asymmetric dimethyl arginine levels in pulmonary hypertension associated with congenital heart disease.

Authors:  Cihat Sanli; Deniz Oguz; Rana Olgunturk; Fatma Sedef Tunaoglu; Serdar Kula; Hatice Pasaoglu; Ozlem Gulbahar; Ayhan Cevik
Journal:  Pediatr Cardiol       Date:  2012-04-21       Impact factor: 1.655

2.  Effect of iloprost on biomarkers in patients with congenital heart disease-pulmonary arterial hypertension.

Authors:  Xiao-Ye Li; Yu Zheng; Yuliang Long; Xiaochun Zhang; Lei Zhang; Dan Tian; Daxin Zhou; Qian-Zhou Lv
Journal:  Clin Exp Pharmacol Physiol       Date:  2017-09       Impact factor: 2.557

3.  Profile of Endothelin-1, Nitric Oxide, and Prostacyclin Levels in Pulmonary Arterial Hypertension Related to Uncorrected Atrial Septal Defect: Results from a Single Center Study in Indonesia.

Authors:  Lucia Kris Dinarti; Anggoro Budi Hartopo; Dyah Wulan Anggrahini; Ahmad Hamim Sadewa; Budi Yuli Setianto; Abdus Samik Wahab
Journal:  Cardiol Res Pract       Date:  2020-01-07       Impact factor: 1.866
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.